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Introduction
Ventilator-associated pneumonia (VAP) is the most
common infectious complication in critically ill patients.
The formation of biofilm on endotracheal tube (ETT)
surface plays an important role in pathogenesis of this
infection, because it facilitates the growth and survival
of microorganisms and difficults the action of antimicro-
bial therapy.
Objectives
The aim of this study is to evaluate the influence of the
persistence of viable microorganisms in the ETT biofilm
on clinical and microbiological response to VAP.
Methods
All patients over 18 years old admitted to the Intensive
Care Unit of the Hospital Universitario and Politecnico
la Fe (Valencia, Spain), undergoing mechanical ventila-
tion and with VAP diagnosis were included. Clinical and
microbiological data were collected at the moment of
inclusion and on days 3 and 7 after VAP diagnosis.
After ETT removal, ETT was washed and a piece of
0.5 cm length was cut and sonicated and the resulting
material was quantitatively cultured (100 uL blood agar
plate with counting of colonies with 100 uL in isolation
in chocolate blood agar). Clinical response (resolution of
VAP signs: fever, high leucocyte count and respiratory
purulence) was evaluated at day 3 and day 7. Median
and interquartile range (IR) was calculated for continu-
ous variables, and absolute and relative frequencies for
discrete variables. Statistical analysis was done by chi-
square test.
Results
23 patients with VAP diagnosis were included, 60%
men, age 55 years (IR: 51 - 67), APACHE II 22 (IR: 15 -
25). The median of days of mechanical ventilation was
17 days (IR: 13 - 20) and until VAP diagnosis was 11
days (IR: 6 - 14). The most common etiological agents
were gram-negative bacilli producers of extended-spec-
trum beta-lactamases (ESBL) (43.6%), multidrug resis-
tant (MDR) P. aeruginosa (17.4%), MDR A. baumannii
(17.4%) and methicillin-sensitive S. aureus (17.4%). 83%
of patients received an appropriate empiric antibiotic
treatment. Median SOFA scale at VAP diagnosis was
5 (IR: 3 - 8). EET biofilm (persistence of viable microor-
ganisms after sample sonication) was detected in 61% of
the cases. No differences were observed according to the
appropriateness of initial empiric treatment (78.6% vs.
80%; p 0.728) or the use of inhaled antibiotics such as
tobramycin or colistin (42.8% vs. 20%; p 0.366). ETT
biofilm was associated with lower percentages of clinical
response on days 3 (7% vs. 20 %; p 0.468) and day 7
(21.4% vs. 60%; p 0.176).
Conclusion
Persistence of viable and potentially infectious microor-
ganisms on ETT biofilm is a common phenomenon after
VAP and is not influenced by the use of systemic or
inhaled antibiotics. Although our sample size does not
allow drawing conclusions, the microbiological persis-
tence seems to be associated with a worse VAP clinical
response.
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